Horizon Therapeutics plc to Release Third-Quarter 2022 Financial Results and Host Webcast on Nov. 2, 2022

Rhea-AI Summary

Horizon Therapeutics (NASDAQ: HZNP) will release its third-quarter 2022 financial results on Wednesday, Nov. 2, 2022. The management will host a live webcast at 8 a.m. Eastern Time to discuss the financial and operating outcomes. Investors can access the webcast via the company's investor relations website. A replay will be available two hours post-webcast. Horizon focuses on developing treatments for rare, autoimmune, and inflammatory diseases, emphasizing a commitment to impactful therapies.

Positive

• Scheduled Q3 2022 earnings release indicates transparency and investor engagement.
• Live webcast allows for real-time interaction with management.

Negative

• None.

DUBLIN--(BUSINESS WIRE)-- Horizon Therapeutics plc (Nasdaq: HZNP) announced today that it will release its third-quarter 2022 financial results on Wednesday, Nov. 2, 2022. Following the announcement, Horizon’s management will host a live webcast at 8 a.m. Eastern Time to review the Company’s financial and operating results.

The live webcast may be accessed at http://ir.horizontherapeutics.com. Please connect to the Company’s website at least 15 minutes prior to the live webcast to ensure adequate time for any software download that may be needed to access the webcast. A replay will be available approximately two hours after the live webcast.

About Horizon

Horizon is a global biotechnology company focused on the discovery, development and commercialization of medicines that address critical needs for people impacted by rare, autoimmune and severe inflammatory diseases. Our pipeline is purposeful: We apply scientific expertise and courage to bring clinically meaningful therapies to patients. We believe science and compassion must work together to transform lives. For more information on how we go to incredible lengths to impact lives, visit www.horizontherapeutics.com and follow us on Twitter, LinkedIn, Instagram and Facebook.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221006005160/en/

Horizon Contacts:

Investor Relations:

Tina Ventura

Senior Vice President, Chief Investor Relations Officer

Investor-relations@horizontherapeutics.com

U.S. Media:

Geoff Curtis

Executive Vice President, Corporate Affairs & Chief Communication Officer

media@horizontherapeutics.com

Ireland Media:

Gordon MRM

Ray Gordon

ray@gordonmrm.ie

Source: Horizon Therapeutics plc

FAQ

When will Horizon Therapeutics release its Q3 2022 financial results?

Horizon Therapeutics will release its Q3 2022 financial results on Wednesday, Nov. 2, 2022.

What time is Horizon Therapeutics' live webcast for its Q3 financial results?

The live webcast will take place at 8 a.m. Eastern Time.

How can I access the Q3 2022 earnings webcast for HZNP?

You can access the Q3 2022 earnings webcast at the Horizon Therapeutics investor relations website.

What is Horizon Therapeutics focused on?

Horizon Therapeutics is focused on developing medicines for rare, autoimmune, and severe inflammatory diseases.